Effect of placental circulating T cells expressing CD16 on multiple hematological and solid tumor cancers through combination with various monoclonal antibodies.

Rituxan (rituximab) - Roche

Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca

PT-CD16VS - Celularity

Erbitux (cetuximab) - Eli Lilly, EMD Serono

Bavencio (avelumab) - EMD Serono

https://meetings.asco.org/abstracts-presentations/233972/

Kathy Karasiewicz-Mendez; Kristina Tess; Mansour Djedaini; Chenfei Huang; Joseph Gleason; Shengchen Lin; Natalia Ruggeri Barbaro; John Fitzgerald; Shuyang He; Robert Hariri; Adrian Kilcoyne

Apr 25, 2024